Literature DB >> 10794473

Spectroscopic studies of copper(II) and iron(II) complexes of adriamycin.

M Feng1, Y Yang, P He, Y Fang.   

Abstract

The complexes of adriamycin (ADM) with Cu(II) and Fe(II) have been studied by visible absorption, circular dichroism (CD) and fluorescence spectra, respectively. In Tris buffer at pH 7.0, either metal ions forms a single species with adriamycin: Cu(ADM)2 or Fe(ADM)3. Interaction of these two complexes with various biological molecules has been examined. It is shown that some amino acids, glutathione and albumin are able to remove the Cu(II) ion from Cu(II)-ADM complex, releasing the free drug. However, Fe(II)-ADM keeps in an undissociated form under the same conditions. The possibility of Fe(II) ADM as a new alternative drug has been discussed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10794473     DOI: 10.1016/s1386-1425(99)00157-2

Source DB:  PubMed          Journal:  Spectrochim Acta A Mol Biomol Spectrosc        ISSN: 1386-1425            Impact factor:   4.098


  8 in total

1.  Complete regression of local cancer using temperature-sensitive liposomes combined with ultrasound-mediated hyperthermia.

Authors:  Azadeh Kheirolomoom; Chun-Yen Lai; Sarah M Tam; Lisa M Mahakian; Elizabeth S Ingham; Katherine D Watson; Katherine W Ferrara
Journal:  J Control Release       Date:  2013-08-28       Impact factor: 9.776

2.  RGD-modified apoferritin nanoparticles for efficient drug delivery to tumors.

Authors:  Zipeng Zhen; Wei Tang; Hongmin Chen; Xin Lin; Trever Todd; Geoffrey Wang; Taku Cowger; Xiaoyuan Chen; Jin Xie
Journal:  ACS Nano       Date:  2013-06-04       Impact factor: 15.881

3.  Ultrasound ablation enhances drug accumulation and survival in mammary carcinoma models.

Authors:  Andrew W Wong; Brett Z Fite; Yu Liu; Azadeh Kheirolomoom; Jai W Seo; Katherine D Watson; Lisa M Mahakian; Sarah M Tam; Hua Zhang; Josquin Foiret; Alexander D Borowsky; Katherine W Ferrara
Journal:  J Clin Invest       Date:  2015-11-23       Impact factor: 14.808

4.  Yolk-shell nanovesicles endow glutathione-responsive concurrent drug release and T1 MRI activation for cancer theranostics.

Authors:  Dahai Liu; Zijian Zhou; Xinyu Wang; Hongzhang Deng; Lin Sun; Haixin Lin; Fei Kang; Yong Zhang; Zhantong Wang; Weijing Yang; Lang Rao; Kuikun Yang; Guocan Yu; Jianshi Du; Zheyu Shen; Xiaoyuan Chen
Journal:  Biomaterials       Date:  2020-03-16       Impact factor: 12.479

5.  A Co(III) Complex of 1-Amino-4-hydroxy-9,10-anthraquinone Exhibits Apoptotic Action against MCF-7 Human Breast Cancer Cells.

Authors:  Somenath Banerjee; Sanjay Roy; Dhanasekaran Dharumadurai; Balaji Perumalsamy; Ramasamy Thirumurugan; Saurabh Das; Asoke Prasun Chattopadhyay; Partha Sarathi Guin
Journal:  ACS Omega       Date:  2021-12-29

6.  Tumor-specific activatable biopolymer nanoparticles stabilized by hydroxyethyl starch prodrug for self-amplified cooperative cancer therapy.

Authors:  Yuxuan Xiong; Zibing Wang; Qiang Wang; Qingyuan Deng; Jitang Chen; Jianshuang Wei; Xiaoquan Yang; Xiangliang Yang; Zifu Li
Journal:  Theranostics       Date:  2022-01-01       Impact factor: 11.600

Review 7.  Mechanistic Insights of Chelator Complexes with Essential Transition Metals: Antioxidant/Pro-Oxidant Activity and Applications in Medicine.

Authors:  Viktor A Timoshnikov; Olga Yu Selyutina; Nikolay E Polyakov; Victoria Didichenko; George J Kontoghiorghes
Journal:  Int J Mol Sci       Date:  2022-01-23       Impact factor: 5.923

8.  Newly Synthesized Doxorubicin Complexes with Selected Metals-Synthesis, Structure and Anti-Breast Cancer Activity.

Authors:  Agata Jabłońska-Trypuć; Grzegorz Świderski; Rafał Krętowski; Włodzimierz Lewandowski
Journal:  Molecules       Date:  2017-07-04       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.